Access Aims to Develop Oral Drug-Delivery Technology for RNAi Therapeutics

The technology, dubbed Cobalamin, is based on the body's natural vitamin B12 uptake mechanism, and involves merging a polymer and active pharmaceutical ingredient to make a nanoparticle, which is then coated with the vitamin.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.